ImmunoGen is a clinical-stage biotechnology company that develops targeted anticancer therapeutics with its proprietary antibody-drug conjugate technology. The Company's lead product candidate, mirvetuximab soravtansine, is a potential treatment for folate receptor α-positive ovarian cancers and other solid tumors. Leading healthcare companies have licensed rights to use ImmunoGen's technology to develop novel anticancer therapies, and Roche's marketed product, Kadcyla, utilizes ImmunoGen's ADC technology.

Employee Rating

3.0More
TypePublic
HQWaltham, US
Founded1981
Size (employees)293 (est)-4%
Websiteimmunogen.com
ImmunoGen was founded in 1981 and is headquartered in Waltham, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

ImmunoGen Office Locations

ImmunoGen has offices in Waltham, Norwood and Brentwood
Waltham, (HQ)
830 Winter St
Norwood,
333 Providence Hwy
Show all (3)
Report incorrect company information

ImmunoGen Financials and Metrics

ImmunoGen Revenue

ImmunoGen's revenue was reported to be $115.45 m in FY, 2017
USD

Revenue (Q3, 2018)

10.9m

Net income (Q3, 2018)

(46.8m)

EBIT (Q3, 2018)

(45.5m)

Market capitalization (4-Dec-2018)

826.0m

Closing stock price (4-Dec-2018)

5.5

Cash (30-Sep-2018)

303.2m
ImmunoGen's current market capitalization is $826 m.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017

Revenue

59.9m85.5m60.0m115.4m

Revenue growth, %

43%(30%)

General and administrative expense

24.5m28.2m36.9m33.9m

R&D expense

107.0m111.8m148.1m139.7m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

17.2m30.1m6.9m13.2m48.3m11.4m14.9m18.0m19.7m7.7m28.5m39.0m8.5m19.8m9.3m10.9m

General and administrative expense

6.5m5.4m6.0m7.1m6.9m7.0m8.3m8.1m11.2m9.5m8.1m8.8m7.9m10.0m8.7m8.3m

R&D expense

22.0m20.9m38.3m28.0m27.6m25.7m35.1m38.2m36.1m32.9m32.9m35.3m31.7m44.8m38.7m47.2m

Operating expense total

28.6m26.3m44.3m35.1m34.5m32.7m43.5m46.3m47.3m46.5m41.4m44.2m39.6m56.6m48.0m56.5m
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017

Cash

142.3m278.1m245.0m267.1m

Accounts Receivable

1.9m5.1m883.0k2.6m

Inventories

3.0m2.9m907.0k1.0m

Current Assets

150.8m292.2m254.8m276.3m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

174.8m178.1m164.1m121.8m106.6m111.8m247.8m212.3m182.9m196.0m126.6m150.3m194.9m218.4m345.1m303.2m

Accounts Receivable

5.8m3.8m36.0k1.8m3.1m754.0k6.8m803.0k104.0k316.0k3.9m1.0m2.5m34.0k19.0k2.1m

Inventories

1.7m3.0m2.5m2.1m1.9m2.7m1.2m1.5m908.0k2.0m3.2m3.5m2.2m368.0k1.9m1.9m

Current Assets

187.7m189.5m172.3m128.3m114.4m119.1m262.0m223.2m193.3m207.3m142.1m161.4m207.0m247.4m364.6m322.7m
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(71.4m)(60.7m)(144.8m)(96.0m)

Depreciation and Amortization

4.6m5.5m5.3m6.0m

Inventories

(2.2m)15.0k2.0m1.2m

Accounts Payable

321.0k3.3m2.6m771.0k
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Net Income

(11.2m)(7.4m)(44.9m)(22.3m)(8.6m)(30.3m)(33.7m)(67.0m)(98.9m)(44.7m)(17.3m)(26.2m)(82.9m)(38.6m)(80.2m)(127.0m)

Depreciation and Amortization

1.2m2.3m3.4m1.4m2.8m4.2m1.1m2.4m3.8m1.5m1.5m2.9m4.3m2.5m5.1m6.2m

Inventories

(968.0k)(2.3m)(1.8m)835.0k1.0m248.0k1.7m1.4m2.0m(1.1m)(1.0m)(1.3m)(51.0k)670.0k(852.0k)(900.0k)

Accounts Payable

(1.4m)(686.0k)245.0k138.0k794.0k1.5m1.6m3.2m796.0k(2.1m)(2.5m)(2.4m)(993.0k)(757.0k)3.9m1.4m
Show all financial metrics
Report incorrect company information

ImmunoGen Online and Social Media Presence

Embed Graph
Report incorrect company information

ImmunoGen Company Life and Culture

Report incorrect company information

ImmunoGen Frequently Asked Questions

  • When was ImmunoGen founded?

    ImmunoGen was founded in 1981.

  • How many employees does ImmunoGen have?

    ImmunoGen has 293 employees.

  • What is ImmunoGen revenue?

    Latest ImmunoGen annual revenue is $115.4 m.

  • What is ImmunoGen revenue per employee?

    Latest ImmunoGen revenue per employee is $394 k.

  • Who are ImmunoGen competitors?

    Competitors of ImmunoGen include Aptevo Therapeutics, Cleveland BioLabs and Heat Biologics.

  • Where is ImmunoGen headquarters?

    ImmunoGen headquarters is located at 830 Winter St, Waltham.

  • Where are ImmunoGen offices?

    ImmunoGen has offices in Waltham, Norwood and Brentwood.

  • How many offices does ImmunoGen have?

    ImmunoGen has 3 offices.